CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Preventing Cervical Cancer and Other HPV-Related Diseases CME
E.J. Mayeaux, MD; Mark Spitzer, MD
Disclosures

Release Date: July 29, 2005; Valid for credit through July 29, 2006

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


This CME activity "Preventing Cervical Cancer and Other HPV-Related Diseases" is based on transcripts and slides of presentations as originally presented on March 9, 2005 and June 20, 2005.

Contents of This CME Activity
This activity is offered in two formats. Please choose one of the versions:

    Flash Version
    (A multimedia presentation with synchronized audio and slides.)
    Note: Macromedia's Flash Player 5 plug-in is required to view the Flash version.
    Download the Macromedia Flash Player 5 plug-In:

    Get Flash 5

    --OR--

    Slides with transcript:

  1. Epidemiology and Economic Impact of HPV-Related Diseases
    by Mark Spitzer, MD
    Epidemiology of Human Papillomavirus-Related Diseases
    Costs of Human Papillomavirus-Related Diseases
    Sexual Activity and Human Papillomavirus Infection and Other Risk Factors
    Natural History of Human Papillomavirus Infection
    Pathology and Biology of Human Papillomavirus
    Clinical Manifestations and Diagnosis of Human Papillomavirus Infection: Genital Warts
    Clinical Manifestations of Human Papillomavirus Infection: Cervical Abnormalities
    Diagnosis of Cervical Abnormalities

  2. HPV Vaccine Trials
    by E.J. Mayeaux, MD
    The Human Papillomavirus Vaccine Trials: Introduction
    Trial of a Human Papillomavirus-16 Virus-Like Particles Vaccine
    Phase 2 Trial of a Bivalent Human Papillomavirus -16/18 Virus-Like Particle Vaccine: Efficacy
    Phase 2 Trial of a Bivalent Human Papillomavirus -16/18 Virus-Like Particle Vaccine: Safety
    Phase 2 Trial of a Quadrivalent Human Papillomavirus Vaccine: Study Background and Design
    Phase 2 Trial of a Quadrivalent Human Papillomavirus Vaccine: Efficacy
    Phase 2 Trial of a Quadrivalent Human Papillomavirus Vaccine: Safety and Conclusions
    Phase 3 Trial of a Quadrivalent Human Papillomavirus Vaccine
    Overcoming Barriers to Human Papillomavirus Vaccine Acceptance

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

 
Copyright © 2005 The Postgraduate Institute for Medicine.
Merck Vaccine Division
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
 
Postgraduate Institute for Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). The Postgraduate Institute for Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.0 Category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Estimated time to complete this activity: 1 hour

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.